We are
headed to
#ASGCT2025
headed to
Evercrisp Biosciences Showcases Preclinical Research Progress in Two Presentations at ASGCT 2025 Annual Meeting
Evercrisp Biosciences is pleased to announce two presentations at the
American Society of Gene +
Cell Therapy (ASGCT)
28th Annual Meeting
May 13-17, 2025 | New Orleans, Louisiana
Presentation details:
Computationally Designed Miniproteins Enable Tissue-Specific Oligonucleotide Delivery Through Cell Surface Receptor-Targeting
Oral Presentation
Wednesday May 14, 2025
Oral Abstract Session:
- Oligonucleotide Therapeutics
Date and time:
- Wednesday, May 14, 3:45 PM - 5:30 PM
Location:
- Room 291-292, Ernest N. Morial Convention Center
Presenter:
- Benjamin Spangler, Ph.D., Vice President and Head of Chemistry, Evercrisp Biosciences
Computationally Designed Miniproteins Enable Precise And Potent In Vivo Delivery Of Gene Editors To Challenging Tissues (Poster 1178)
Poster Presentation
Wednesday May 14, 2025
Poster Presentation Session
- Wednesday Poster Reception
Date and time:
- Wednesday, May 14, 5.30-7.30 PM
Location:
- Poster Hall I1-I2, Ernest N. Morial Convention Center
Presenter:
- Geoffrey Berguig, Ph.D., Chief Technology Officer, Evercrisp Biosciences